Human tauopathies including Alzheimer’s disease, progressive supranuclear palsy and related disorders, are characterized by deposition of pathological forms of tau, synaptic dysfunction and neuronal loss. This evidence concerns the gene MAPT and Classical progressive supranuclear palsy.